AbbVie Inc (ABBV)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$222.50

Buy

$224.34

arrow-down$-0.66 (-0.29%)

Prices updated at 13 Dec 2025, 00:42 EST

Prices minimum 15 mins delay

Prices in USD

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	54,318m	56,334m
	33,903m	39,430m
	13,535m	11,894m
	24.92	21.11
	4,863m	4,278m
	17,172m	14,910m
Sales, General and administrative	12,872m	14,752m
Interest expenses	2,224m	2,808m
Provision for income taxes	1,377m	-570m
Operating expenses	20,368m	27,536m
Income before taxes	6,250m	3,716m
Net income available to common shareholders	4,820m	4,238m
	2.73	2.4
Net interest income	-1,684m	-2,160m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	2.72	2.39
Free cash flow per share	13.9377	8.8116
Book value/share	6.8485	3.4171
Debt equity ratio	5.038031	18.147368

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	33,002m	25,582m
Current liabilities	37,841m	38,749m
Total capital	62,554m	63,665m
Total debt	59,385m	67,144m
Total equity	10,360m	3,325m
Total non current liabilities	-	-
Loans	52,194m	60,340m
Total assets	134,711m	135,161m
Total liabilities	-	-
Cash and cash equivalents	12,814m	5,524m
Common stock	1,766m	1,765m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	9,201m	12,814m
Cash dividends paid	-10,539m	-11,025m
	22,062m	17,832m
Investments (gains) losses	-2,009m	-20,820m
	12,814m	5,524m
Net income	-	-
	22,839m	18,806m
	-777m	-974m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.